Efficacy and Safety of Lenalidomide in Patients With IgG4-Related Disease
Clinical trial NCT07719543 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07719543
- Sponsor
- Chinese PLA General Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2030-12-31
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.